Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
Adult
Blood Glucose
Male
Adolescent
Individuality
Multicenter Studies as Topic/statistics & numerical data
Young Adult
03 medical and health sciences
Blood Glucose/drug effects
Insulin Infusion Systems
0302 clinical medicine
Humans
Hypoglycemic Agents
Insulin
Multicenter Studies as Topic
Child
Blood Glucose Self-Monitoring/instrumentation
Aged
Randomized Controlled Trials as Topic
Retrospective Studies
Cross-Over Studies
Dose-Response Relationship, Drug
Randomized Controlled Trials as Topic/statistics & numerical data
Blood Glucose Self-Monitoring
Age Factors
Infant
Diabetes Mellitus, Type 1/blood
Middle Aged
Hypoglycemic Agents/administration & dosage
3. Good health
Diabetes Mellitus, Type 1
Child, Preschool
Female
Insulin/administration & dosage
DOI:
10.2337/dc18-2625
Publication Date:
2019-06-14T19:52:11Z
AUTHORS (133)
ABSTRACT
OBJECTIVE
To quantify age-related variability of insulin needs during day and night closed-loop insulin delivery.
RESEARCH DESIGN AND METHODS
We retrospectively analyzed data from hybrid closed-loop studies involving young children (1–6 years old, n = 20), children (7–12 years, n = 21), adolescents (13–17 years, n = 15), and adults (>18 years, n = 58) with type 1 diabetes. The coefficient of variation quantified variability of insulin needs during 3 weeks of unrestricted-living hybrid closed-loop use.
RESULTS
Data from 2,365 nights and 2,367 days in 114 participants were analyzed. The coefficient of variation of insulin delivery was higher in young children compared with adults (mean difference at nighttime 10.7 percentage points [95% CI 2.9–18.4], P = 0.003; daytime 6.4 percentage points [95% CI 2.0–10.9], P = 0.002) and compared with adolescents (mean difference at nighttime 10.2 percentage points [95% CI 0.0–20.4], P = 0.049; daytime 7.0 percentage points [95% CI 1.1–12.8], P = 0.014).
CONCLUSIONS
Diabetes management in young children is complicated by higher variability in insulin requirements, supporting fast-track clinical practice adoption of closed-loop in this vulnerable population.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (12)
CITATIONS (68)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....